Status:
COMPLETED
THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL
Lead Sponsor:
Universitas Sriwijaya
Collaborating Sponsors:
M. Djamil General Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to determine effect of arginine and glutamine on outcome of COVID-19 patients. The main questions it aims to answer are: -to test the effect of oral nutritional sup...
Eligibility Criteria
Inclusion
- Patients confirmed positive for COVID-19
- Age over 17 years
- The patient can take food orally
Exclusion
- Patients with restricted fluid intake
- Patients who cannot take food orally
- suffering from diabetes mellitus and kidney failure
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06004375
Start Date
May 1 2021
End Date
May 30 2023
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. M. Djamil General Hospital
Padang, West Sumatera, Indonesia, 25176